Synchron Secures $200 Million in Series D Funding
Synchron has raised $200 million in Series D financing to accelerate the development and commercialization of its brain-computer interface (BCI) technology.
Advancing Stentrode™ BCI Platform
The new funding will support the commercial rollout of the Stentrode™ platform, an innovative endovascular electrode array designed to enable brain-computer communication.
Expansion of AI and Engineering Operations
Synchron plans to grow its artificial intelligence and engineering teams in both New York and San Diego to further advance its technology.
Synchron Media Contact Kimberly Ha [email protected]
Author's summary: Synchron's substantial investment raises the potential for transformative brain-computer interfaces through advanced AI and engineering, boosting the commercialization of the Stentrode™ system.